Gastrointestinal Cancer
255
53
66
103
Key Insights
Highlights
Success Rate
83% trial completion
Published Results
33 trials with published results (13%)
Research Maturity
103 completed trials (40% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.2%
21 terminated out of 255 trials
83.1%
-3.5% vs benchmark
4%
9 trials in Phase 3/4
32%
33 of 103 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 103 completed trials
Clinical Trials (255)
Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)
Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
Harvesting Cells for Experimental Cancer Treatments
Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer
sFOLFOXIRI in Advanced Gastroesophageal Cancer, (SAGE)
Advancing Nursing Practices in Hospital Oncology Care
Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients
Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population
SURGE: Supporting Utility and Representation in Genomics-based Cancer Trial Enrollment (Intervention)
Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
Preoperative Frailty and Postoperative Outcomes in Older Patients Undergoing Surgery for Gastrointestinal Cancer
Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT
Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal Cancer
Resilience and Equity in Aging, Cancer, and Health (REACH)
Frailty in Patients With Gastrointestinal Cancer Who Are Undergoing Major Surgery
Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue